Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Blood AdvancesOpen Access

Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP

View Full Paper
Ask AI
Bookmark
Share

Authors

RARuah AlyamanyDHDamon E. HoughtonMSMeera Sridharan

Discussion

Loading...

Member takes

Overview

Retrospective cohort study evaluates thrombosis incidence in ITP patients post-splenectomy, suggesting further research on TPO-RA implications.

Key Points

  • Thrombosis incidence was higher in the TPO-RA group, indicating potential risk factors in post-splenectomy patients.
  • Among patients, 42% were treated with TPO-RA, and thrombosis affected 17 in the TPO-RA group compared to 14 in the non-TPO-RA group.
  • This retrospective cohort study analyzed data from ITP patients who underwent splenectomy to determine safety outcomes.
  • Findings indicate a need for tailored thromboprophylaxis and further investigation into TPO-RA's safety after splenectomy.

Cite This Study

Alyamany et al. (2025) studied this question.

synapsesocial.com/papers/68c238d2b210217d6477973dhttps://doi.org/10.1182/bloodadvances.2025017902
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thrombotic risk with thrombopoietin receptor agonists in immune thrombocytopenia: Real-world evidence from a multicenter Japanese study.2025
  2. 2Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients2025
  3. 3Bridging the gaps between randomized controlled trials and real-world use of thrombopoietin receptor agonists for adult primary immune thrombocytopenia: a systematic review and meta-analysis2025 · 1 citations
  4. 4Assessment of thrombotic risk and pathophysiological mechanisms of splenectomy-associated hypercoagulability in patients with immune thrombocytopenia2025
  5. 5Differential expression of coagulation and inflammation genes in ITP patients before and after treatment with thrombopoietin receptor agonists2025